Shilpa Medicare informs about company updates

04 Oct 2016 Evaluate

Shilpa Medicare has informed that the Company has received an approval from the United States Food & Drug Administration (USPDA) for Azacitidine - Injection Anda of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

323.15 -2.80 (-0.86%)
17-Dec-2025 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.50
Dr. Reddys Lab 1278.30
Cipla 1493.15
Zydus Lifesciences 920.00
Lupin 2116.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×